Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: BIOMARKERS, TUMOR - BLOOD , . Treffer: 45

2021

Stitz, R; Buder, A; Silye, R; Baumgartner, B; Pühringer, F; Filipits, M; Oberndorfer, E; Heitzer, E Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA.
EXP MOL PATHOL. 2021; 123: 104685 Doi: 10.1016/j.yexmp.2021.104685
Web of Science PubMed FullText FullText_MUG

 

Unseld, M; Belic, J; Pierer, K; Zhou, Q; Moser, T; Bauer, R; Piringer, G; Gerger, A; Siebenhüner, A; Speicher, M; Heitzer, E; Prager, GW A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Int J Cancer. 2021; 148(6):1452-1461 Doi: 10.1002/ijc.33303 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Penack, O; Peczynski, C; van der Werf, S; Finke, J; Ganser, A; Schoemans, H; Pavlu, J; Niittyvuopio, R; Schroyens, W; Kaynar, L; Blau, IW; van der Velden, WJFM; Sierra, J; Cortelezzi, A; Wulf, G; Turlure, P; Rovira, M; Ozkurt, Z; Pascual-Cascon, MJ; Moreira, MC; Clausen, J; Greinix, H; Duarte, RF; Basak, GW Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party.
Front Immunol. 2020; 11:586-586 Doi: 10.3389/fimmu.2020.00586 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weiland, T; Eckert, A; Tomazic, PV; Wolf, A; Pondorfer, P; Vasicek, S; Graupp, M; Holzmeister, C; Moser, U; Andrianakis, A; Kangler, G; Kiss, P; Brcic, L; Kappler, M; Wickenhauser, C; Haak, A; Krüger, M; Al-Nawas, B; Blatt, S; Brockmeyer, N; Skaletz-Rorowski, A; Potthoff, A; French, LE; Charnowski, S; Reinholz, M; Kaufmann, AM; Thies, S; Lambrecht, HG; Seliger, B; Wild, DC; Thurnher, D DRH1 - a novel blood-based HPV tumour marker.
EBioMedicine. 2020; 56:102804 Doi: 10.1016/j.ebiom.2020.102804 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Jilg, S; Rassner, M; Maier, J; Waldeck, S; Kehl, V; Follo, M; Philipp, U; Sauter, A; Specht, K; Mitschke, J; Lange, T; Bauer, S; Jost, PJ; Peschel, C; Duyster, J; Gaiser, T; Hohenberger, P; von Bubnoff, N Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST).
Int J Cancer. 2019; 145(8):2292-2303 Doi: 10.1002/ijc.32282
Web of Science PubMed FullText FullText_MUG

 

Marcuello, M; Vymetalkova, V; Neves, RPL; Duran-Sanchon, S; Vedeld, HM; Tham, E; van Dalum, G; Flügen, G; Garcia-Barberan, V; Fijneman, RJ; Castells, A; Vodicka, P; Lind, GE; Stoecklein, NH; Heitzer, E; Gironella, M Circulating biomarkers for early detection and clinical management of colorectal cancer.
MOL ASPECTS MED. 2019; 69(9): 107-122. Doi: 10.1016/j.mam.2019.06.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Alunni-Fabbroni, M; Majunke, L; Trapp, EK; Tzschaschel, M; Mahner, S; Fasching, PA; Fehm, T; Schneeweiss, A; Beck, T; Lorenz, R; Friedl, TWP; Janni, W; Rack, B; SUCCESS Study Group Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
BMC Cancer. 2018; 18(1):141-141 Doi: 10.1186/s12885-018-4020-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stöger, H; Gerger, A; Pichler, M; Stotz, M Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Wien Klin Wochenschr. 2018; 130(19-20):569-574 Doi: 10.1007/s00508-018-1383-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90 Doi: 10.1038/bjc.2016.393 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dandachi, N; Tiran, V; Lindenmann, J; Brcic, L; Fink-Neuboeck, N; Kashofer, K; Absenger, G; Bezan, A; Cote, RJ; Datar, R; Balic, M Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Lung Cancer. 2017; 113(46):152-157 Doi: 10.1016/j.lungcan.2017.10.003
Web of Science PubMed FullText FullText_MUG

 

Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Klöters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Oncotarget. 2017; 8(28):46234-46248 Doi: 10.18632/oncotarget.17598 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Perakis, S; Auer, M; Belic, J; Heitzer, E Advances in Circulating Tumor DNA Analysis.
Adv Clin Chem. 2017; 80(10):73-153 Doi: 10.1016/bs.acc.2016.11.005
Web of Science PubMed FullText FullText_MUG

 

2016

Hepp, P; Andergassen, U; Jäger, B; Trapp, E; Alunni-Fabbroni, M; Friedl, TW; Hecker, N; Lorenz, R; Fasching, P; Schneeweiss, A; Fehm, T; Janni, W; Rack, B Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Anticancer Res. 2016; 36(9):4771-4776 Doi: 10.21873/anticanres.11034 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoda, MA; Dong, Y; Rozsas, A; Klikovits, T; Laszlo, V; Ghanim, B; Stockhammer, P; Ozsvar, J; Jakopovic, M; Samarzija, M; Brcic, L; Bendek, M; Szirtes, I; Reid, G; Kirschner, MB; Kao, SC; Opitz, I; Weder, W; Frauenfelder, T; Nguyen-Kim, TD; Aigner, C; Klepetko, W; van Zandwijk, N; Berger, W; Dome, B; Grusch, M; Hegedus, B Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Eur J Cancer. 2016; 63(1):64-73 Doi: 10.1016/j.ejca.2016.04.018 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hügel, R; Muendlein, A; Volbeding, L; Drexel, H; Richtig, E; Wehkamp, U; Painsi, C; Lange-Asschenfeldt, B; Hauschild, A; Egberts, F Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanoma.
Melanoma Res. 2016; 26(4):354-360 Doi: 10.1097/CMR.0000000000000269
Web of Science PubMed FullText FullText_MUG

 

Ling, H; Pickard, K; Ivan, C; Isella, C; Ikuo, M; Mitter, R; Spizzo, R; Bullock, M; Braicu, C; Pileczki, V; Vincent, K; Pichler, M; Stiegelbauer, V; Hoefler, G; Almeida, MI; Hsiao, A; Zhang, X; Primrose, J; Packham, G; Liu, K; Bojja, K; Gafà, R; Xiao, L; Rossi, S; Song, JH; Vannini, I; Fanini, F; Kopetz, S; Zweidler-McKay, P; Wang, X; Ionescu, C; Irimie, A; Fabbri, M; Lanza, G; Hamilton, SR; Berindan-Neagoe, I; Medico, E; Mirnezami, A; Calin, GA; Nicoloso, MS The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Gut. 2016; 65(6):977-989 Doi: 10.1136/gutjnl-2015-309372 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Perakis, SO; Thomas, JE; Pichler, M Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Adv Exp Med Biol. 2016; 937(4):183-204 Doi: 10.1007/978-3-319-42059-2_10
Web of Science PubMed FullText FullText_MUG

 

Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 Doi: 10.1038/bjc.2016.325 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rack, B; Jückstock, J; Trapp, E; Weissenbacher, T; Alunni-Fabbroni, M; Schramm, A; Widschwendter, P; Lato, K; Zwingers, T; Lorenz, R; Tesch, H; Schneeweiss, A; Fasching, P; Mahner, S; Beckmann, MW; Lichtenegger, W; Janni, W; SUCCESS Study Group CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Tumour Biol. 2016; 37(10):13769-13775 Doi: 10.1007/s13277-016-5171-2
Web of Science PubMed FullText FullText_MUG

 

Schwameis, R; Grimm, C; Brodowicz, T; Petru, E; Hefler-Frischmuth, K; Staudigl, C; Reinthaller, A; Heinze, G; Polterauer, S; Polterauer, M Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma.
Sci Rep. 2016; 6(5):33757-33757 Doi: 10.1038/srep33757 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Selzer, E; Grah, A; Heiduschka, G; Kornek, G; Thurnher, D Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Wien Klin Wochenschr. 2016; 128(9-10):320-328 Doi: 10.1007/s00508-016-0963-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330 Doi: 10.1136/jclinpath-2015-203356
Web of Science PubMed FullText FullText_MUG

 

Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611 Doi: 10.1007/s00345-015-1646-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551 Doi: 10.1136/jclinpath-2014-202683
Web of Science PubMed FullText FullText_MUG

 

Heitzer, E; Ulz, P; Geigl, JB Circulating tumor DNA as a liquid biopsy for cancer.
Clin Chem. 2015; 61(1):112-123 Doi: 10.1373/clinchem.2014.222679 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
Breast. 2015; 24(5):667-672 Doi: 10.1016/j.breast.2015.08.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Reichl, P; Fang, M; Starlinger, P; Staufer, K; Nenutil, R; Muller, P; Greplova, K; Valik, D; Dooley, S; Brostjan, C; Gruenberger, T; Shen, J; Man, K; Trauner, M; Yu, J; Gao, CF; Mikulits, W Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
Int J Cancer. 2015; 137(2):385-394 Doi: 10.1002/ijc.29394 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sadeghi, M; Lahdou, I; Oweira, H; Daniel, V; Terness, P; Schmidt, J; Weiss, KH; Longerich, T; Schemmer, P; Opelz, G; Mehrabi, A Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
Br J Cancer. 2015; 113(5):756-762 Doi: 10.1038/bjc.2015.227 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schwameis, R; Grimm, C; Petru, E; Natter, C; Staudigl, C; Lamm, W; Koelbl, H; Krainer, M; Brodowicz, T; Reinthaller, A; Polterauer, S The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.
PLoS One. 2015; 10(8):e0133838-e0133838 Doi: 10.1371/journal.pone.0133838 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stotz, M; Szkandera, J; Stojakovic, T; Seidel, J; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Seggewies, F; Hoefler, G; Gerger, A; Pichler, M The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Clin Chem Lab Med. 2015; 53(3):499-506 Doi: 10.1515/cclm-2014-0447
Web of Science PubMed FullText FullText_MUG

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473 Doi: 10.1007/s00345-014-1459-2
Web of Science PubMed FullText FullText_MUG

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Eur J Cancer. 2015; 51(5):610-619 Doi: 10.1016/j.ejca.2015.01.002
Web of Science PubMed FullText FullText_MUG

 

2014

Bezan, A; Gerger, A; Pichler, M MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(6):2709-2713
Web of Science PubMed

 

Lindenmann, J; Fink-Neuboeck, N; Koesslbacher, M; Pichler, M; Stojakovic, T; Roller, RE; Maier, A; Anegg, U; Smolle, J; Smolle-Juettner, FM The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.
J Surg Oncol. 2014; 110(6):645-650 Doi: 10.1002/jso.23711
Web of Science PubMed FullText FullText_MUG

 

Lozanovski, VJ; Houben, P; Hinz, U; Hackert, T; Herr, I; Schemmer, P Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial.
Trials. 2014; 15(2):204-204 Doi: 10.1186/1745-6215-15-204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mohan, S; Heitzer, E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler, M; Gerger, A; Eisner, F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
PLoS Genet. 2014; 10(3):e1004271-e1004271 Doi: 10.1371/journal.pgen.1004271 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
PLoS One. 2014; 9(8):e104730-e104730 Doi: 10.1371/journal.pone.0104730 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Szappanos, S; Farkas, R; Lőcsei, Z; László, Z; Kalincsák, J; Bellyei, S; Sebestyén, Z; Csapó, L; Sebestyén, K; Halász, J; Musch, Z; Beöthe, T; Farkas, L; Mangel, L [New methods in the treatment of localized prostate cancer: use of dynamic arc therapy and kV cone-beam CT positioning].
Orv Hetil. 2014; 155(32): 1265-72. Doi: 10.1556/OH.2014.29883
PubMed FullText FullText_MUG

 

Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144 Doi: 10.1002/jso.23458
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Leidenberger, P; Wald, A; Hohneder, A; Kühs, U; Mischinger, J; Aufderklamm, S; Gakis, G; Blumenstock, G; Stenzl, A; Schwentner, C Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
BJU Int. 2014; 113(1):152-159 Doi: 10.1111/j.1464-410X.2012.11759.x
Web of Science PubMed FullText FullText_MUG

 

2013

Longerich, T; Sommer, CM; Schemmer, P; Weiss, KH 33-year-old woman with upper abdominal pain].
Dtsch Med Wochenschr. 2013; 138(20):1059-1060 Doi: 10.1055/s-0032-1332937 (- Case Report)
PubMed FullText FullText_MUG

 

Partl, R; Richtig, E; Avian, A; Berghold, A; Kapp, KS Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Int J Radiat Oncol Biol Phys. 2013; 85(3):662-666 Doi: 10.1016/j.ijrobp.2012.06.009
Web of Science PubMed FullText FullText_MUG

 

2008

Brunner, M; Thurnher, D; Heiduschka, G; Grasl, MCh; Brostjan, C; Erovic, BM Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
J Surg Oncol. 2008; 98(7):545-550 Doi: 10.1002/jso.21139
Web of Science PubMed FullText FullText_MUG

 

Graefen, M; Ahyai, S; Heuer, R; Salomon, G; Schlomm, T; Isbarn, H; Budäus, L; Heinzer, H; Huland, H [Active surveillance for prostate cancer].
Urologe A. 2008; 47(3):261-9 Doi: 10.1007/s00120-008-1638-0
Web of Science PubMed FullText FullText_MUG

 

2004

Wolfsberger, S; Wunderer, J; Zachenhofer, I; Czech, T; Böcher-Schwarz, HG; Hainfellner, J; Knosp, E Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
Acta Neurochir (Wien). 2004; 146(8):831-9 Doi: 10.1007/s00701-004-0298-0
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum